Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
Blood|May 2, 2013
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemiaEric Padron, Jeffrey S Painter, Sateesh Kunigal, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Blood Cancer Journal|February 2, 2022
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patientsAbhishek A Mangaonkar, Terra L Lasho, Rhett P Ketterling, et al.
Nature Genetics|February 16, 2026
Modeling the evolutionary dynamics of clonal hematopoiesisSadegh Marzban, Thomas Stiehl, Zhuoer Xie, et al.
Transplantation and Cellular Therapy|July 30, 2023
Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National RegistryNancy Gillis, Eric Padron, Tao Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 1, 2024
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell TransplantFilip Ionescu, Jerel C David, Apoorva Ravichandran, et al.
Blood Advances|November 25, 2025
Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts OutcomesDavid A Sallman, Amy F McLemore, Rami S Komrokji, et al.
Annals of Hematology|July 2, 2026
Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024)Utsav Joshi, Fatima Tuz Zahra, Pujan Patel, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2023
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene FusionYumeng Zhang, Lynn Nguyen, Chuanyi M Lu, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemiaHanqian L Carlson, Thai T Nguyen, Samantha Tauchmann, et al.
Pageof 21